One of the main EGFR pathways is the phosphatidylinositol-3-kinase (PI3K) and its downstream molecule serine/threonine protein kinase B (PKB or Akt) that inhibits the apoptotic effect and, when overactivated, induces cancer development [40]. Here, AKT1 is linked to cancer.